Conserved noncoding sequence-9 regulates NFATc1-mediated IL-10 expression in B cells to control inflammatory...

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• B cell-derived Interleukin-10 (IL-10) is vital for regulating inflammatory responses.
• Mechanisms controlling IL-10 expression in B cells are not fully understood.

Purpose of the Study:

• To identify and characterize regulatory elements controlling IL-10 production in B cells.
• To elucidate the role of NFATc1 and conserved noncoding sequences in IL-10 regulation.
• To investigate the implications of this pathway in inflammatory disease models.

Main Methods:

• Genomic analyses to identify regulatory elements.
• Chromatin looping assays to study enhancer-promoter interactions.
• Flow cytometry to quantify IL-10 production in specific B cell subsets.
• Mouse models of LPS-induced sepsis to assess in vivo function.

Main Results:

• A conserved noncoding sequence (CNS-9) was identified as a critical enhancer for IL-10 expression in mouse B cells.
• CNS-9 binds the transcription factor NFATc1, mediating chromatin looping to the IL-10 promoter.
• B1a cells are the primary source of B cell IL-10, regulated by NFATc1-CNS-9.
• Deletion of CNS-9 or NFATc1 impaired IL-10 production, worsened sepsis outcomes, and reduced survival.
• The human homolog, CNS-12, exhibits similar NFATc1-dependent regulatory function.

Conclusions:

• A conserved regulatory pathway involving CNS-9 and NFATc1 controls IL-10 production in B cells.
• This pathway is essential for effective inflammatory response regulation and survival in sepsis.
• Findings offer insights into inflammatory disease pathogenesis and potential therapeutic targets.